Due: November 20, 2023 AutoDoc Request for Project Proposals (RPP) focused on identifying a system of sensor suites that can reliably and passively collect the core data needed to identify casualty status, key tasks performed Read More
DUE: February 23, 2024 Funding opportunity supporting impactful, large marine debris removal projects that will improve the resilience of the coastal and marine environment and implement strategies to prevent the re-accumulation of marine debris.
DUE: February 7, 2024 Funding available to provide a proof-of-principle for a novel strategy for Alzheimer Disease and Alzheimer Related Dementias (AD/ADRD) immunotherapies.
DUE: February 1, 2024 Supporting research designed to advance fundamental understanding of basic disease-related molecular mechanisms of vascular contributions to cognitive impairment and dementia (VCID).
DUE: February 14, 2024 Funding opportunity to support the development/enhancement of infrastructure (e.g., tools, surveys, biospecimens, data) for Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD) neuroscience research in low- and middle-income countries (LMICs) in Africa.
Due January 10, 2024 Improved Coverage for Surface Cleaners on Glazed Ceramic Surfaces Challenge Brief
Due: January 22, 2024 Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI) The Medical Technology Enterprise Consortium (MTEC) is excited to post this Request for Project Proposals (RPP) to solicit current MTEC members for a broad Read More
Due: November 13, 2023 The objective of this challenge is to develop initial proof of concept prototypes using Artificial Intelligence (AI) Large language models to automate the process of conducting ISD analysis, requirements development, for Read More
Due: November 14, 2023 This initiative seeks proposals from the small business community to support the development of compact tools and devices capable of manufacturing key chemical intermediates at the benchtop for research operations.
Due: November 14, 2023 The development of an accurate, inexpensive home test for Prostate Specific Antigen (PSA) is both an unmet need and an NCI priority for reducing cancer mortality by half within 25 years.
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.